| Title | A Phase I Dose-Escalation and Dose-Expansion Study Evaluating the Safety, Pharmacokinetics, and Activity of GDC-6036 in Patients With Advanced or Metastatic Solid Tumors With a KRAS G12C Mutation |
| Protocole ID | GO42144 |
| ClinicalTrials.gov ID | NCT04449874 |
| Cancer Type(s) | Solid Tumors |
| Phase | Phase I |
| Stage | Advanced or metastatic disease |
| Study Type | Treatment |
| Drug | GDC-6036 |
| Institution |
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
 HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
3755 rue de la Côte Ste. Catherine, Montréal, QC, H3T 1E2 |
| City | |
| Principal Investigator |
Dr. Wilson Miller |
| Coordinator |
Ralph Waked 514-340-8222 poste 26823 |
| Status | Recruiting |
| Activation Date | |
| Eligibility Criteria | |
| Exclusion Criteria | |
Groupe d'étude en oncologie du Québec